Brent L. Larson
2011
In 2011, Brent L. Larson earned a total compensation of $275K as Executive Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 22% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $43,875 |
---|---|
Salary | $222,637 |
Other | $8,450 |
Total | $274,962 |
Larson received $222.6K in salary, accounting for 81% of the total pay in 2011.
Larson also received $43.9K in non-equity incentive plan and $8.5K in other compensation.
Rankings
In 2011, Brent L. Larson's compensation ranked 9,574th out of 10,747 executives tracked by ExecPay. In other words, Larson earned more than 10.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,574 out of 10,747 | 11th |
Division Manufacturing | 3,564 out of 3,960 | 10th |
Major group Chemicals And Allied Products | 911 out of 1,033 | 12th |
Industry group Drugs | 686 out of 781 | 12th |
Industry In Vitro and In Vivo Diagnostic Substances | 37 out of 43 | 14th |
Source: SEC filing on June 6, 2014.
Larson's colleagues
We found five more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2011.
2011
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2011
Mark Pykett
Navidea Biopharmaceuticals
Chief Executive Officer
2011
David Bupp
Navidea Biopharmaceuticals
Chief Executive Officer
2011
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2011
Rodger Brown
Navidea Biopharmaceuticals